Suggested Topics within your search.
Showing 1 - 20 results of 36 for search '"Treat-and-extend"', query time: 1.81s Refine Results
  1. 1
    24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting
    Subjects: “...Treat and extend...”
    Get full text
    Article
  2. 2
    Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with “Treat-and-Extend” Regimen—Its Usefulness and Problems
    Subjects: “...treat-and-extend regimen...”
    Get full text
    Article
  3. 3
    Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
    Subjects: “...Treat-and-extend...”
    Get full text
    Article
  4. 4
    Efficacy of Modified Treat-and-Extend Aflibercept Regimen for Macular Edema Due to Branch Retinal Vein Occlusion: 1-Year Prospective Study
    Subjects: “...modified treat-and-extend regimen...”
    Get full text
    Article
  5. 5
    Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre Trial
    Subjects: “...Treat and extend...”
    Get full text
    Article
  6. 6
    Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion
    Subjects: “...Treat and extend...”
    Get full text
    Article
  7. 7
    External Limiting Membrane Disruption Predicts Long-Term Outcome in Strict Treat-And-Extend Regimen in Neovascular Age-Related Macular Degeneration
    by Laura Hoffmann, Katja Hatz, Katja Hatz
    Published 2021-09-01
    Subjects: “...treat-and-extend...”
    Get full text
    Article
  8. 8
    Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study
    Subjects: “...Treat and extend...”
    Get full text
    Article
  9. 9
    Treat and extend compared to pro re nata regimen in neovascular age-related macular degeneration
    by Rodolfo Garretón
    Published 2020-08-01
    Subjects: “...treat and extend...”
    Get full text
    Article
  10. 10
    Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
    Subjects: “...treat-and-extend...”
    Get full text
    Article
  11. 11
    Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
    Subjects: “...treat and extend...”
    Get full text
    Article
  12. 12
    Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
    Subjects: “...Treat-and-extend...”
    Get full text
    Article
  13. 13
    A simulation tool for better management of retinal services
    Subjects: “...Treat and extend...”
    Get full text
    Article
  14. 14
    Clinical Outcomes of a Treat and Extend Regimen with Intravitreal Aflibercept Injections in Patients with Diabetic Macular Edema: Experience in Clinical Practice
    Subjects: “...Treat and extend...”
    Get full text
    Article
  15. 15
    Anatomical and functional response after conversion to aflibercept using the treat-and-extend regimen protocol in bevacizumab treatment-resistant wet age-related macular degeneration
    by Taipale C, Laine I, Tuuminen R
    Published 2018-12-01
    Subjects: “...treat-and-extend regimen protocol...”
    Get full text
    Article
  16. 16
    Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
    by Khanani AM, Gahn GM, Koci MM, Dang JM, Brown SM, Hill LF
    Published 2019-02-01
    Subjects: “...treat and extend protocol...”
    Get full text
    Article
  17. 17
    Pharmacoeconomic research of using aflibercept in patients with the wet age-related macular degeneration
    Subjects: “...treat-and-extend...”
    Get full text
    Article
  18. 18
    Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
    Subjects: “...Treat and extend...”
    Get full text
    Article
  19. 19
    Individualized Treatment of Neovascular Age-Related Macular Degeneration: What are Patients Gaining? Or Losing?
    by Michael W. Stewart
    Published 2015-05-01
    Subjects: “...treat and extend...”
    Get full text
    Article
  20. 20
    Treat and Extend Treatment Interval Patterns with Anti-VEGF Therapy in nAMD Patients
    Subjects: “...treat and extend...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search